Efficacy of Preconditioned Adipose-Derived Stem Cells in Fat Grafting

NCT05610878 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-12-31

No results posted yet for this study

Summary

The aim of this study is to evaluate the comparison of therapeutic potential of curcumin preconditioned adipose derived stem cells (ASCs) enrichment fat grafting, naïve ASCs enrichment fat grafting and conventional fat grafting to correct facial contour deformities that cause aesthetic complications in patients.

Conditions

  • Romberg Disease
  • Craniofacial Microsomia
  • Burn Scar
  • Post-Traumatic Scar (Disorder)

Interventions

BIOLOGICAL

Cultured ASCs enrichment fat grafting

Patients will undergo conventional fat harvesting. Harvested fat will be mixed with cultured ASCs and grafted into recipient site with 1,00,000 cells/ml injected fat

BIOLOGICAL

Curcumin-preconditioned ASCs enrichment fat grafting

Patients will undergo conventional fat harvesting. Harvested fat will be mixed with cultured ASCs preconditioned with curcumin and grafted into recipient site with 1,00,000 cells/ml injected fat

OTHER

Conventional fat grafting

Patients will undergo conventional fat harvesting and grafting of fat into recipient site

Sponsors & Collaborators

  • Centre of Excellence in Molecular Biology, University of the Punjab, Lahore

    collaborator UNKNOWN
  • Higher Education Commission (Pakistan)

    collaborator OTHER
  • Jinnah Burn and Reconstructive Surgery Centre, Lahore

    collaborator OTHER_GOV
  • University of the Punjab

    lead OTHER

Principal Investigators

  • Azra Mehmood, PhD · Center of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore

  • Sheikh Riazuddin, PhD · Jinnah Burn and Reconstructive Surgery Center (JB&RSC), Lahore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-20
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05610878 on ClinicalTrials.gov